OBJECTIVE: To assess whether a ketodiet, a combination of ketoanalogs of essential amino acids (KAs) and a very low-protein diet, retards progression of chronic renal failure and maintains nutritional status. DESIGN: A prospective, randomized, double-blind, placebo-controlled trial. SETTING: Nephrology outpatient department in Northern Railways Central Hospital, New Delhi, India. PATIENTS: Thirty-four patients in predialytic stages of chronic renal failure (CRF), randomized to 2 comparable groups in terms of age, sex distribution, blood pressure control, etiology, use of angiotensin converting enzyme inhibitors, serum creatinine, glomerular filtration rate (GFR), and body mass index (BMI). INTERVENTION: Subjects randomly received either 0.6 g/kg/d protein plus placebo (n = 16) or 0.3 g/kg/d protein plus tablets of KAs (Ketosteril; Fresenius Kabi, Germany) (n = 18) for 9 months. A dietician administered the diet as well as the KAs or the placebo to the patients. OUTCOME MEASURES: Changes in GFR and renal and nutritional parameters were measured. RESULTS: Mean (+/-SD) GFR measured by the 99mTc-DTPA (99 m technetium diethylenetri-aminepentaaceticacid) plasma sample method was unchanged in the ketodiet group: 28.1 +/-8.8 (before) and 27.6 +/-10.1 mL/min/1.73 m2 (after the study) (P =.72). However, it significantly decreased from 28.6 +/-17.6 to 22.5 +/-15.9 mL/min/1.73 m2 in the placebo group (P =.015). Serum creatinine before and after the study in the ketodiet group was 2.26 +/-1.03 mg/dL and 2.07 +/-0.8 mg/dL (P =.90) and in the placebo group was 2.37 +/-0.85 and 3.52 +/-2.9 mg/dL (P =.066), respectively. In both groups the mean BMI did not change from 25.4 +/-4.2 to 24.5 +/-4.2 kg/m2 (P =.46) for ketodiet and from 25.0 +/-6.8 to 23.9 +/-4.1 kg/m2 (P =.39) for the placebo group. Serum total proteins decreased significantly (P =.038) in the placebo group, and serum albumin showed a trend (P =.061) toward reduction,
